MKS (NASDAQ:MKSI) Posts Earnings Results, Beats Estimates By $0.55 EPS

MKS (NASDAQ:MKSI) released its quarterly earnings results on Wednesday. The scientific and technical instruments company reported $4.18 EPS for the quarter, topping analysts’ consensus estimates of $3.63 by $0.55, FiscalAI reports. The firm had revenue of $1.41 billion during the quarter, compared to analysts’ expectations of $1.36 billion. MKS had a net margin of 10.15% and a return on equity of 24.72%. The firm’s revenue for the quarter was up 43.0% compared to the same quarter last year. During the same period in the previous year, the company earned $1.93 EPS.

MKS Trading Down 7.3%

MKSI traded down $14.13 during trading on Thursday, hitting $180.82. 2,168,863 shares of the stock were exchanged, compared to its average volume of 1,383,992. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.72 and a current ratio of 1.14. The firm has a 50 day simple moving average of $243.61 and a 200 day simple moving average of $277.24. The firm has a market cap of $12.23 billion, a price-to-earnings ratio of 29.04, a P/E/G ratio of 0.43 and a beta of 2.14. MKS has a 1 year low of $134.74 and a 1 year high of $447.62.

MKS Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, December 7th. Investors of record on Wednesday, November 25th will be issued a $0.25 dividend. The ex-dividend date is Wednesday, November 25th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 0.6%. MKS’s payout ratio is presently 15.95%.

MKS News Summary

Here are the key news stories impacting MKS this week:

• Positive Sentiment: Q3 beat expectations: Adjusted EPS was $4.18, above the roughly $3.63–$3.64 consensus, and revenue of $1.41 billion topped the $1.36 billion estimate. Revenue rose 43% year over year. MKS Q3 Adjusted Earnings, Revenue Rise; Q4 Guidance Issued
• Positive Sentiment: Upbeat Q4 earnings outlook: MKS forecast adjusted EPS of $4.62–$5.38, supporting expectations for continued earnings strength. MKS Q4 Adjusted EPS Outlook
• Positive Sentiment: Capital returns: The board authorized up to $500 million in share repurchases—up to 3.6% of shares—and declared a $0.25 quarterly dividend. MKS Announces Share Repurchase Program and Dividend
• Neutral Sentiment: Despite the favorable results and announcements, MKSI traded lower in the supplied market data. The articles provide no specific negative catalyst to explain the move.

Analyst Ratings Changes

Several research analysts have issued reports on MKSI shares. Morgan Stanley dropped their target price on MKS from $345.00 to $330.00 and set an “overweight” rating for the company in a research report on Monday, October 26th. JPMorgan Chase & Co. increased their price target on MKS from $365.00 to $380.00 and gave the stock an “overweight” rating in a report on Friday, August 7th. Cantor Fitzgerald restated an “overweight” rating and set a $600.00 price objective on shares of MKS in a report on Monday, August 3rd. Wall Street Zen raised MKS from a “buy” rating to a “strong-buy” rating in a research report on Saturday, August 8th. Finally, Citigroup upped their price objective on MKS from $425.00 to $430.00 and gave the company a “buy” rating in a research report on Friday, August 7th. One analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $374.86.

MKS declared that its Board of Directors has initiated a stock repurchase program on Wednesday, November 4th that permits the company to buy back $500 million in outstanding shares. This repurchase authorization permits the scientific and technical instruments company to reacquire up to 3.6% of its shares through open market purchases. Share repurchase programs are typically a sign that the company’s board of directors believes its shares are undervalued.

Insiders Place Their Bets

In related news, Director Elizabeth Mora sold 300 shares of the company’s stock in a transaction dated Tuesday, September 1st. The shares were sold at an average price of $250.96, for a total value of $75,288.00. Following the completion of the sale, the director directly owned 18,845 shares of the company’s stock, valued at $4,729,341.20. This represents a 1.57% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO John Tseng-Chung Lee sold 10,000 shares of the stock in a transaction dated Friday, August 14th. The stock was sold at an average price of $302.01, for a total transaction of $3,020,100.00. Following the transaction, the chief executive officer owned 134,776 shares in the company, valued at approximately $40,703,699.76. The trade was a 6.91% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.57% of the stock is currently owned by corporate insiders.

About MKS

MKS Instruments, Inc (NASDAQ: MKSI) develops technologies that enable precision control and measurement in manufacturing and research environments. The company provides instruments, components, systems and process-control solutions used to measure and control pressure, flow, vacuum, gas delivery, temperature and other critical production conditions.

Its product portfolio includes vacuum solutions, pressure and flow-control instruments, gas and vapor delivery systems, plasma and reactive-gas technologies, power delivery systems, process-monitoring equipment, analytical instruments and materials-characterization tools.